Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$8.94 - $18.35 $895,269 - $1.84 Million
100,142 Added 261.07%
138,500 $2.54 Million
Q3 2022

Nov 14, 2022

BUY
$6.12 - $9.5 $234,750 - $364,401
38,358 New
38,358 $358,000

Others Institutions Holding CVRX

About CVRx, Inc.


  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $338M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track G2 Investment Partners Management LLC Portfolio

Follow G2 Investment Partners Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of G2 Investment Partners Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on G2 Investment Partners Management LLC with notifications on news.